查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1499544

医疗保健契约製造市场：按製造类型、最终用户划分 - 2024-2030 年全球预测

Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年医疗保健契约製造市场规模为1,860亿美元，预计2024年将达2016.8亿美元，2030年将达3,292.2亿美元，复合年增长率为8.49%。

医疗保健契约製造市场由向其他医疗保健组织提供各种服务的公司组成，从药物处方和市场开拓到製造医疗保健设备和组件。这个市场允许医疗保健公司外包部分业务，降低成本，提高灵活性，并利用先进的製造技术和专业知识。推动该市场成长的关键因素包括对学名药的需求增加、慢性病的流行、对先进医疗设备的需求以及新治疗方式的快速采用。然而，严格的监管合规性、各种国际标准以及在降低成本的同时保持高品质流程的压力是阻碍市场成长的主要阻碍因素。医疗保健契约製造市场的机会是由技术进步驱动的，例如设备製造中的 3D 列印、个人化医疗保健以及日益重要的监管合规性。此外，持续投资研发创新生技药品和医疗保健设备并适应不断发展的数位医疗保健格局可能会进一步加剧市场竞争。

主要市场统计
基准年[2023] 1860亿美元
预测年份 [2024] 2016.8亿美元
预测年份 [2030] 3292.2亿美元
复合年增长率（%） 8.49%

区域洞察

由于其高度发达的医疗基础设施和严格的监管要求，美洲正在经历显着的市场成长。由于越来越注重降低医疗保健成本，北美地区对受託製造厂商(CMO) 的外包（尤其是药品和医疗保健设备）正在迅速增加。由于政府的大力支持以及学术界和工业界的合作，欧洲国家处于医疗保健研究和开发的前沿。公共和私营部门在个人化医疗、基因组学、数位健康解决方案和先进疗法等领域的投资不断增加，进一步支持了欧洲、中东和非洲医疗保健契约製造的成长。由于国内需求成长、成本优势和技术进步，中国、日本和印度的医疗保健契约製造正在显着增长。亚太地区正在成为医疗保健设备和药品的製造地，导致受託製造公司在亚太市场的策略扩张。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在医疗保健契约製造市场中的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对医疗保健契约製造市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该细分市场竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在医疗保健契约製造市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行概述

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药公司端到端外包趋势增加
      • 契约製造製造商增加对先进製造技术的投资
      • 对一站式合约开发和製造组织的需求不断增加
    • 抑制因素
      • 外包中的合规问题以及严格的法规和法律体制
    • 机会
      • 更加关注核子卫生保健和特种药物
      • 生物治疗的需求不断增加
    • 任务
      • 影响医疗保健契约製造组织盈利的产能利用率问题
  • 市场区隔分析
    • 製造类型：製造流程的进步提供客製化解决方案，透过契约製造满足不同的客户需求。
    • 最终用户：契约製造开始开发高度复杂的生物产品。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 医疗保健合约契约製造市场：依製造类型

  • 介绍
  • 配件製造
  • 组装製造
  • 零件製造
  • 装置製造
  • 药品製造

第七章 医疗保健契约製造市场：依最终用户分类

  • 介绍
  • 医疗保健设备公司
  • 製药和生物製药公司

第八章美洲医疗保健合约契约製造市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太医疗保健契约製造市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的医疗保健契约製造市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Biomerics 宣布与 Precision Concepts Medical 合併
    • PCI Pharma 宣布投资 5,000 万美元扩建伊利诺伊州注射厂计划
    • Medisurge 与 Signal Medical 宣布策略伙伴关係
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-8C74ADFC054D

[190 Pages Report] The Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024, at a CAGR 8.49% to reach USD 329.22 billion by 2030.

The healthcare contract manufacturing market comprises firms that offer a range of services, from drug formulation and development to medical devices and components manufacturing for other healthcare organizations. This market enables healthcare companies to outsource certain aspects of their operations, which can lead to lowered costs, increased flexibility, and access to advanced manufacturing technologies and expertise. The major factors propelling the growth of the healthcare contract manufacturing market include the increasing demand for generic medicines, the rising prevalence of chronic diseases, the need for advanced medical devices, and the surge in the introduction of new therapeutic methodologies. However, stringent regulatory compliances, varying international standards, and the pressure of maintaining high-quality processes while reducing costs are the major restraining factors hindering market growth. The opportunities within the healthcare contract manufacturing market are driven by technological advancements such as 3D printing in device manufacturing, personalized medicine, and the growing importance of regulatory compliance. Additionally, sustained investments in R&D for developing innovative biologics and medical devices and adapting to the evolving digital healthcare landscape could further enhance market competitiveness.

KEY MARKET STATISTICS
Base Year [2023] USD 186.00 billion
Estimated Year [2024] USD 201.68 billion
Forecast Year [2030] USD 329.22 billion
CAGR (%) 8.49%

Regional Insights

The Americas has significant market growth due to highly developed healthcare infrastructure and stringent regulatory requirements in the region. The increased focus on bringing down healthcare costs has led to a surge in outsourcing to contract manufacturing organizations (CMOs), particularly for pharmaceuticals and medical devices in the North American region. European Countries are at the forefront of healthcare research and development, bolstered by strong government support and collaborations between academia and industry. The growing investments from the public and private sectors in areas such as personalized medicine, genomics, digital health solutions, and advanced therapies further drive the growth of healthcare contract manufacturing in the EMEA region. China, Japan, and India are witnessing significant growth in healthcare contract manufacturing due to rising domestic demand, cost advantages, and technological advances. The Asia Pacific (APAC) region has emerged as a medical device and pharmaceutical manufacturing hub, leading to strategic business expansions by contract manufacturing organizations in the APAC market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Healthcare Contract Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • Rising investments in advanced manufacturing technologies by contract manufacturers
      • Increasing demand for one-stop-shop contract development & manufacturing organization
    • Market Restraints
      • Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • Market Opportunities
      • Growing focus on nuclear medicine and specialty drugs
      • Increasing need for biological therapies
    • Market Challenges
      • Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • Market Segmentation Analysis
    • Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Healthcare Contract Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Healthcare Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Biomerics Announces Merger with Precision Concepts Medical

Biomerics LLC, a major player in vertically integrated contract manufacturing in the interventional medical device sector, has announced its strategic merger with Precision Concepts Medical. This significant transaction encompasses the acquisition of Precision Concepts International's (PCI) medical business and Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. This merger between Biomerics LLC and Precision Concepts Medical strengthened their presence in the healthcare contract manufacturing landscape. [Published On: 2023-05-17]

PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site

PCI Pharma Services, a biopharmaceutical contract manufacturing organization, recently announced its plans for a significant USD 50 million expansion at its Rockford, Illinois-based sterile injectables facility. The project is expected to involve the construction of a state-of-the-art 200,000-square-foot site that aims to substantially enhance the plant's production capacity for injectable drug-device combination products. The ambitious expansion initiative underscores PCI Pharma Services' commitment to addressing the growing demand for high-quality sterile injectable solutions while maintaining its position as a trusted and reliable partner in the biopharmaceutical sector. [Published On: 2023-03-16]

Medisurge and Signal Medical Announce Strategic Partnership

Medisurge, a healthcare contract manufacturing player, has announced its exclusive partnership with Signal Medical Corporation. Signal Medical has built a solid reputation for manufacturing high-quality knee and hip implants and providing advanced instrument systems to orthopedic surgeons. This strategic partnership between Medisurge and Signal Medical facilitates growth expansion for both companies in the competitive orthopedic market. By combining their expertise and resources, the partnership aims to establish an even stronger presence and provide enhanced services to clients within the industry. [Published On: 2023-01-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Healthcare Contract Manufacturing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Manufacturing Type
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing
    • Pharmaceutical Manufacturing
      • Advanced Drug Delivery Formulations
      • API/Bulk Drugs
      • Finished Dose Formulations
      • Packaging
  • End-Users
    • Medical Device Companies
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Rising investments in advanced manufacturing technologies by contract manufacturers
      • 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on nuclear medicine and specialty drugs
      • 5.1.3.2. Increasing need for biological therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • 5.2.2. End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Healthcare Contract Manufacturing Market, by Manufacturing Type

  • 6.1. Introduction
  • 6.2. Accessories Manufacturing
  • 6.3. Assembly Manufacturing
  • 6.4. Component Manufacturing
  • 6.5. Device Manufacturing
  • 6.6. Pharmaceutical Manufacturing

7. Healthcare Contract Manufacturing Market, by End-Users

  • 7.1. Introduction
  • 7.2. Medical Device Companies
  • 7.3. Pharmaceutical & Biopharmaceutical Companies

8. Americas Healthcare Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Biomerics Announces Merger with Precision Concepts Medical
    • 11.3.2. PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
    • 11.3.3. Medisurge and Signal Medical Announce Strategic Partnership
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HEALTHCARE CONTRACT MANUFACTURING MARKET DYNAMICS
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HEALTHCARE CONTRACT MA